Polyrizon's Mucoadhesive Drug Delivery Platform Patent Published

Key Highlights

• Polyrizon announced the publication of U.S. patent application No. US 2024/0358741 A1.
• The patent application is titled "Mucoadhesive Polymers for Nasal Drug Delivery."
• It covers Polyrizon's proprietary Trap & Target (T&T) mucoadhesive polymer technology platform.
• The technology aims to enhance drug absorption and retention in nasal mucosa.
• The platform may support delivery of anti-inflammatory drugs, vaccines, and biologics.
• It describes biocompatible compositions forming a uniform and durable film on mucosal surfaces.
• The technology combines sulfated polysaccharides with hydrophilic polymers, partially crosslinked with divalent ions.
• Potential uses include oral and nasal drug delivery systems like sprays, gels, and inhalation products.